Linkage of Transgender Individuals to PrEP

Status Completed

Clinical Trial Summary

CCTG 602 is a multisite demonstration project to evaluate the effectiveness of facilitated linkage to PrEP using a community-based transgender PrEP outreach worker (T-POWr) versus standard of care (SOC).

Clinical Trial Description

Up to 500 self-identified transgender / gender non-conforming persons seeking daily Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV will be enrolled into this study. Each participant will be followed up to 28 weeks after enrollment. The primary endpoint, successful linkage to a PrEP evaluation visit, will be measured after 30 days of enrollment. Participants expressing interest in PrEP will be referred to the regional transgender PrEP outreach work (T-POWr) via phone call. Enrolled participants will be randomized (1:1) to either SOC PrEP linkage vs T-POWr facilitated PrEP linkage. Participants randomized into the SOC Arm will receive an HIV risk assessment, PrEP education, and an appointment for a linkage visit. Participants randomized into the T-POWr arm will receive SOC and a thorough client-centered case management evaluation that will assess needs including access to health insurance, general health care, assessment of current hormone administration, housing, mental health care, domestic violence care, substance use treatment, and other services. Participants will be contacted at Week 4 to verify linkage, and at Weeks 16 and 28 to assess PrEP and HIV status, and access to referred services. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03191474
Study type	Interventional
Source	University of California, San Diego
Contact
Status	Completed
Phase	N/A
Start date	July 28, 2017
Completion date	March 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00065741` - Botanical/Drug Interactions in HIV: Glucuronidation	Phase 1
Completed	`NCT00056953` - Peer Mentors for Adolescents in HIV Affected Families	Phase 2
Completed	`NCT00047931` - HIV-1 Vaccine Test in Uninfected Adult Volunteers	Phase 1
Completed	`NCT03995862` - Evaluation of Pre-Exposure Prophylaxis Against HIV in Alpine Region
Completed	`NCT00006327` - Effectiveness of AIDSVAX B/E Vaccine in Intravenous Drug Users in Bangkok, Thailand	Phase 3
Completed	`NCT03086200` - Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals	N/A
Completed	`NCT00076817` - Safety and Effectiveness of Administering an HIV Vaccine in the Groin Versus the Arm	Phase 1
Completed	`NCT00121121` - Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers	Phase 1
Completed	`NCT00009685` - HIV-1 Vaccine Test in Uninfected Adult Volunteers	Phase 1
Completed	`NCT00031304` - Screening Protocol for HIV Vaccine Studies
Completed	`NCT00055237` - Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients	Phase 2
Completed	`NCT02125773` - Pre-exposure Prophylaxis Accessibility Research and Evaluation 2	N/A
Terminated	`NCT00789789` - Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials	N/A
Completed	`NCT01761643` - CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM	Phase 4
Completed	`NCT01418235` - Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults	Phase 1
Completed	`NCT00028119` - HIV Incidence and Participation Retention in Pune, India
Completed	`NCT00076232` - A Study of Acyclovir to Help Prevent HIV Infection in People With Genital Herpes	Phase 3
Completed	`NCT00004579` - A Study to See Whether Two HIV Vaccines Are Safe and Can Prevent HIV Infection	Phase 1
Active, not recruiting	`NCT00013572` - HIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative Adults	Phase 1
Completed	`NCT00006298` - Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa	N/A